Garra Sabino, Mejlstrup Hymøller Charlotte, Di Molfetta Daria, Zagaria Nicola, Gena Patrizia, Cardone Rosa Angela, Rützler Michael, Birkelund Svend, Calamita Giuseppe
Department of Biosciences, Biotechnologies and Environment, University of Bari Aldo Moro, 70125 Bari, Italy.
Department of Health Science and Technology, Aalborg University, 9220 Aalborg, Denmark.
Cells. 2025 Jun 11;14(12):880. doi: 10.3390/cells14120880.
Peripheral blood leukocytes are able to migrate to the inflamed tissue, and to engulf and kill invading microbes. This requires rapid modifications of cell morphology and volume through fast movements of osmotic water into or out of the cell. In this process, membrane water channels, aquaporins (AQPs), are critical for cell shape changes as AQP-mediated water movement indirectly affects the cell cytoskeleton and, thereby, the signaling cascades. Recent studies have shown that the deletion or gating of two immune cell AQPs, AQP3 and AQP9, impairs inflammation and improves survival in microbial sepsis. Here, we assessed the expression and distribution of AQP3 and AQP9 in human leukocytes and investigated their involvement in the phagocytosis and killing of the Gram-negative pathogenic bacterium , and their role in lipopolysaccharide (LPS)-induced cell migration. By RT-qPCR, AQP3 mRNA was found in peripheral blood mononuclear cells (PBMCs) but it was undetectable in polymorphonuclear white blood cells (PMNs). AQP9 was found both in PBMCs and PMNs, particularly in neutrophil granulocytes. Immunofluorescence confirmed the AQP3 expression in monocytes and, to a lesser degree, in lymphocytes. AQP9 was expressed both in PBMCs and neutrophils. Specific inhibitors of AQP3 (DFP00173) and AQP9 (HTS13286 and RG100204) were used for bacterial phagocytosis and killing studies. No apparent involvement of individually blocked AQP3 or AQP9 was observed in the phagocytosis of by neutrophils or monocytes after 10, 30, or 60 min of bacterial infection. A significant impairment in the phagocytic capacity of monocytes but not neutrophils was observed only when both AQPs were inhibited simultaneously and when the infection lasted for 60 min. No impairment in bacterial clearance was found when AQP3 and AQP9 were individually or simultaneously blocked. PBMC migration was significantly impaired after exposure to the AQP9 blocker RG100204 in the presence or absence of LPS. The AQP3 inhibitor DFP00173 reduced PBMC migration only under LPS exposure. Neutrophil migration was considerably reduced in the presence of RG100204 regardless of whether there was an LPS challenge or not. Taken together, these results indicate critical but distinct involvements for AQP3 and AQP9 in leukocyte motility, while no roles are played in bacterial killing. Further studies are needed in order to understand the precise ways in which these two AQPs intervene during bacterial infections.
外周血白细胞能够迁移至炎症组织,并吞噬和杀灭入侵的微生物。这需要通过渗透水快速进出细胞,从而快速改变细胞形态和体积。在此过程中,膜水通道蛋白(AQP)对细胞形状变化至关重要,因为AQP介导的水运动间接影响细胞骨架,进而影响信号级联反应。最近的研究表明,两种免疫细胞水通道蛋白AQP3和AQP9的缺失或关闭会损害炎症反应,并提高微生物败血症的存活率。在此,我们评估了AQP3和AQP9在人白细胞中的表达和分布,并研究了它们在吞噬和杀灭革兰氏阴性病原菌中的作用,以及它们在脂多糖(LPS)诱导的细胞迁移中的作用。通过逆转录定量聚合酶链反应(RT-qPCR)发现,外周血单核细胞(PBMC)中存在AQP3信使核糖核酸(mRNA),但在多形核白细胞(PMN)中未检测到。在PBMC和PMN中均发现了AQP9,尤其是在中性粒细胞中。免疫荧光证实了AQP3在单核细胞中的表达,在淋巴细胞中的表达程度较低。AQP9在PBMC和中性粒细胞中均有表达。使用AQP3特异性抑制剂(DFP00173)和AQP9特异性抑制剂(HTS13286和RG100204)进行细菌吞噬和杀灭研究。在细菌感染10、30或60分钟后,未观察到单独阻断AQP3或AQP9对中性粒细胞或单核细胞吞噬细菌有明显影响。仅当两种水通道蛋白同时被抑制且感染持续60分钟时,才观察到单核细胞而非中性粒细胞的吞噬能力显著受损。单独或同时阻断AQP3和AQP9时,未发现细菌清除能力受损。在有或无LPS存在的情况下,暴露于AQP9阻断剂RG100204后,PBMC迁移显著受损。仅在LPS暴露下,AQP3抑制剂DFP00173才会降低PBMC迁移。无论是否存在LPS刺激,在RG100204存在的情况下,中性粒细胞迁移均显著减少。综上所述,这些结果表明AQP3和AQP9在白细胞运动中起关键但不同的作用,而在细菌杀灭中不起作用。为了了解这两种水通道蛋白在细菌感染过程中的具体干预方式,还需要进一步研究。
Cochrane Database Syst Rev. 2018-2-6
Health Technol Assess. 2001
Cochrane Database Syst Rev. 2011-7-6
Cochrane Database Syst Rev. 2007-1-24
Cochrane Database Syst Rev. 2022-5-20
Health Technol Assess. 2024-7
Cochrane Database Syst Rev. 2017-12-22
Front Immunol. 2024
Int J Mol Sci. 2024-1-19
Biochem Biophys Res Commun. 2023-10-8
Adv Exp Med Biol. 2023
Adv Exp Med Biol. 2023